APRIL POLITE: Open Payments
NPI 1508565649 · WAXAHACHIE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,062 in 55 payments from 15 companies in 2025. Trend: 2023 $585 · 2024 $667 · 2025 $1,062
Food & beverage: $1,062
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 9 | $230 |
| ABBVIE INC. | 13 | $152 |
| Lundbeck LLC | 8 | $145 |
| Vanda Pharmaceuticals Inc. | 4 | $92 |
| Lilly USA, LLC | 5 | $90 |
| Novartis Pharmaceuticals Corporation | 3 | $80 |
| Biogen, Inc. | 3 | $72 |
| UCB, Inc. | 2 | $53 |
| Celgene Corporation | 2 | $33 |
| Axsome Therapeutics, Inc. | 1 | $29 |
Products named: Leqembi, VYEPTI, PONVORY, KESIMPTA, AMYVID, QULIPTA, Rystiggo, UBRELVY.
Industry payments across TX — which companies pay providers there.
